Bactericidal Permeability Increasing Protein Deficiency Aggravates Acute Colitis in Mice by Increasing the Serum Levels of Lipopolysaccharide
Open Access
- 21 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
Objective: The objective of this study was to understand the role of bactericidal permeability increasing protein (BPI) in the pathogenesis of experimental murine colitis. Methods: We used the Cre-LoxP system to generate BPI knockout (BPI KO) mice. Acute colitis was induced in BPI KO mice and wild-type (WT) mice by subjecting the mice to 5% dextran sulfate sodium (DSS). Mice were observed for symptoms of experimental colitis. The survival of BPI KO mice to infection with Acinetobacter baumannii, a gram-negative bacterium, was also assessed. Results: Southern blot, RT-PCR, and western blot results showed that the 2nd and 3rd exons of the murine Bpi gene were knocked out systemically, confirming successful construction of the BPI KO mouse. BPI KO mice subjected to DSS showed increased symptoms of experimental colitis, increased colonic mucosal damage, increased epithelial permeability, elevated levels of serum LPS, and a disrupted fecal microbiome as compared with WT mice. Furthermore, BPI KO mice challenged intraperitoneally with A. baumannii died sooner than WT mice, and the total number of bacteria in the abdominal cavity, spleen, and liver was increased in BPI KO mice as compared to WT mice. Conclusions: We successfully generated BPI KO mice. The BPI KO mice developed worse colitis than WT mice by increased colitis symptoms and colonic mucosal damage, elevated levels of serum LPS, and a disrupted microbiome. BPI could be a potential target for treatment of ulcerative colitis in humans.Funding Information
- Natural Science Foundation of Beijing Municipality (7172017)
This publication has 29 references indexed in Scilit:
- Infecting mice with recombinant Ad5-BPI23-Fcγ1 virus protects against systemic Escherichia coli challengeJournal of Medical Microbiology, 2012
- Investigating Intestinal Inflammation in DSS-induced Model of IBDJournal of Visualized Experiments, 2012
- A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrowJournal of Leukocyte Biology, 2004
- Extracellular Release of Bactericidal/Permeability-Increasing Protein in Newborn InfantsPediatric Research, 2002
- Extracellular Release of Bactericidal/Permeability-Increasing Protein in Newborn InfantsPediatric Research, 2002
- Enhancement of Neonatal Innate Defense: Effects of Adding an N-Terminal Recombinant Fragment of Bactericidal/Permeability-Increasing Protein on Growth and Tumor Necrosis Factor-Inducing Activity of Gram-Negative Bacteria Tested in Neonatal Cord Blood Ex VivoInfection and Immunity, 2000
- Isolation of Mouse NeutrophilsCurrent Protocols in Immunology, 1997
- Genetic variation among 129 substrains and its importance for targeted mutagenesis in miceNature Genetics, 1997
- Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.JCI Insight, 1992
- Bactericidal mechanisms of the human neutrophil An integrated biochemical and morphological modelScandinavian Journal of Haematology, 1984